LR

Lucas Rascon

IB Inhibrx Biosciences: 4 patents #6 of 26Top 25%
IN Inhibrx: 3 patents #14 of 23Top 65%
RP Regeneron Pharmaceuticals: 1 patents #552 of 810Top 70%
📍 Village of La Jolla, CA: #490 of 2,316 inventorsTop 25%
🗺 California: #82,707 of 386,348 inventorsTop 25%
Overall (All Time): #672,231 of 4,157,543Top 20%
7
Patents All Time

Issued Patents All Time

Showing 1–7 of 7 patents

Patent #TitleCo-InventorsDate
12421315 CLL-1 targeted immunotherapies Jordan Jarjour, Mark Pogson, Wai-Hang Leung, Angelica Sanabria, John C. Timmer +1 more 2025-09-23
12227584 Multivalent and multispecific OX40-binding fusion proteins Brendan P. Eckelman, John C. Timmer, Chelsie Macedo, Kyle S. Jones, Abrahim Hussain +5 more 2025-02-18
12187804 Multivalent and multispecific 41BB-binding proteins Brendan P. Eckelman, John C. Timmer, Chelsie Macedo, Kyle S. Jones, Abrahim Hussain +5 more 2025-01-07
12043667 CLEC12a binding polypeptides and uses thereof Angelica Sanabria, John C. Timmer, Brendan P. Eckelman 2024-07-23
11566078 PDL1-binding proteins Brendan P. Eckelman, John C. Timmer, Chelsie Macedo, Kyle S. Jones, Abrahim Hussain +5 more 2023-01-31
11117972 Multivalent and multispecific OX40-binding fusion proteins Brendan P. Eckelman, John C. Timmer, Chelsie Hata, Kyle S. Jones, Abrahim Hussain +5 more 2021-09-14
10501551 Multivalent and multispecific 41BB-binding fusion proteins Brendan P. Eckelman, John C. Timmer, Chelsie Hata, Kyle S. Jones, Abrahim Hussain +5 more 2019-12-10